IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
In 35 patients with hypertrophic cardiomyopathy, the effects of ivabradine (15 mg/d) and atenolol (50 mg/d) on physical stress tolerability (veloergometry test results) were investigated. Ivabradine and atenolol therapy was associated with increased test time: +1,5 minutes (p<0,01) and +2,4 m...
Main Authors: | P. Kh. Dzhanashiya, I. V. Markelova, N. S. Krylova, E. V. Avdeeva, V. A. Nazarenko, S. A. Nikolenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2010-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1421 |
Similar Items
-
AMIODARONE THYROTOXICOSIS IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2009-06-01) -
PULSE REDUCTION IN MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY (TWO CLINICAL CASES)
by: N. S. Krylova, et al.
Published: (2017-12-01) -
A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris
by: A A Shavarov, et al.
Published: (2013-04-01) -
HYPERTROPHIC CARDIOMYOPATHY, COMPLICATED BIVENTRICULAR HEART FAILURE AND PULMONARY ARTERY THROMBOEMBOLIA, IN AN ELDERLY WOMAN
by: P. Kh. Dzhanashiya, et al.
Published: (2010-04-01) -
Efficacy of ivabradine in idiopathic dilated cardiomyopathy patients with chronic heart failure
by: Sherief Mansour, et al.
Published: (2011-06-01)